There was not a statistically significant difference (p>0.05) between the serum levels of MX1 according to the presence of lymphadenopathy, parotid involvement, arthralgia/arthritis, skin involvement, pulmonary involvement, cryoglobulinemia, hypocomplementemia and neutropenia. This evidence concerns the gene MX1 and arthritic joint disease.